Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Medicina Clinica|June 20, 2001
[Clinical pattern and therapeutic results obtained in Germ-Cell testicular cancer in Spain based on a consecutive series of 1250 patients]J R Germà, X García Del Muro, P Maroto, et al.
Actas Urologicas Espanolas|May 13, 2024
Recommendations on the treatment of metastatic hormone-sensitive prostate cancer: Patient selectionÁ Borque-Fernando, A Zapatero, R Manneh, et al.
European Urology|January 1, 1997
Growing teratoma syndrome: experience of a single institutionP Maroto, J M Tabernero, H Villavicencio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2011
Phase II study of sunitinib as first-line treatment of urothelial cancer patients ineligible to receive cisplatin-based chemotherapy: baseline interleukin-8 and tumor contrast enhancement as potential predictive factors of activityJ Bellmunt, J L González-Larriba, C Prior, et al.
Bone Marrow Transplantation|February 26, 1999
Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantationR Salazar, C Solá, P Maroto, et al.
Hematology (Amsterdam, Netherlands)|June 16, 2001
Bone Marrow Transplantation: Prognostic Factors of Peripheral Blood Stem Cell Mobilization with Cyclophosphamide and Filgrastim (r-metHuG-CSF): The CD34+ Cell Dose Positively Affects the Time to Hematopoietic Recovery and Supportive Requirements after High-Dose ChemotherapyC. Solá, P. Maroto, R. Salazar, et al.
Urologic Oncology|November 15, 2020
Incidence and clinical pattern of contralateral synchronous and metachronous germ cell testicular cancerP Maroto, X García Del Muro, C Valverde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 10, 2011
Phase II study of eribulin mesylate (E7389) in patients with metastatic castration-resistant prostate cancer stratified by prior taxane therapyJ S de Bono, L R Molife, G Sonpavde, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 29, 2020
Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer GroupJ Aparicio, X García Del Muro, P Maroto, et al.
Cancer Metastasis Reviews|August 1, 2015
New advances in genitourinary cancer: evidence gathered in 2014C Suárez, J Puente, E Gallardo, et al.
Pageof 6